Ann: Results of Meeting, page-12

I attended and overall I thought rather positive.

Some notes:

- Yacov was not present, he didn’t receive his visa in time and therefore wouldn’t of been able to make it.

- Steven Wood and Dr Brendan de Kauwe we’re present. Brendan was answering nearly all questions.

- probably the most annoying thing is because Brendan isn’t an executive director he wasn’t able to answer any operational queries.

- all MOU’s are still there. However, most (other than China) have been dependent on the other businesses part of our deal getting themselves sorted out. E.g the Singapore deal requires Singmore to get a fully functioning centre up and running so our products are actually relevant. (This was my take)

- it is expected the company will break even by year end simply from current monitoring services in America. Not including any product sales

- they are equally frustrated with slow CFDA. Company is apparently fully compliant and up to date with all FDA and CDFA requirements and submissions.